Abstract
Purpose of the study: Estimating the prevalence of AF in the general population and during the COVID-19 pandemic. Materials and methods: A review of scientific articles on the features of the course and prevalence of AF against the background of COVID-19 was carried out using a search in the Medline database (PubMed) and an interdisciplinary, scientific-practical, peer-reviewed journal for physicians CONSILIUM MEDICUM 2021.The literature found was analyzed and summarized by the authors of this literature review. Conclusion: Thus, new-onset AF is both a marker of disease severity and a likely cause of adverse outcomes, similar to other manifestations of organ dysfunction during critical illness
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: A.I. Burnasyan Federal Medical Biophysical Center Clinical Bulletin
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
